Reported Earnings • Mar 17
Full year 2025 earnings released: ₩24.00 loss per share (vs ₩660 loss in FY 2024) Full year 2025 results: ₩24.00 loss per share (improved from ₩660 loss in FY 2024). Revenue: ₩19.7b (up 59% from FY 2024). Net loss: ₩192.7m (loss narrowed 96% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 43 percentage points per year, which is a significant difference in performance. 공시 • Feb 25
BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026 BIFIDO Co., Ltd., Annual General Meeting, Mar 19, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea Reported Earnings • Mar 15
Full year 2024 earnings released: ₩660 loss per share (vs ₩132 profit in FY 2023) Full year 2024 results: ₩660 loss per share (down from ₩132 profit in FY 2023). Revenue: ₩12.4b (down 34% from FY 2023). Net loss: ₩5.40b (down ₩6.48b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance. 공시 • Feb 27
BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025 BIFIDO Co., Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 23-16, nonggongdanji-gil, hongcheon-eup, hongcheon-gun, gangwon-do, South Korea New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩25.8b market cap, or US$17.9m). Valuation Update With 7 Day Price Move • Mar 26
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₩6,480, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 29x in the Personal Products industry in South Korea. Total loss to shareholders of 50% over the past three years. Reported Earnings • Mar 22
Full year 2023 earnings released: EPS: ₩132 (vs ₩189 in FY 2022) Full year 2023 results: EPS: ₩132 (down from ₩189 in FY 2022). Revenue: ₩18.6b (up 28% from FY 2022). Net income: ₩1.08b (down 30% from FY 2022). Profit margin: 5.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. New Risk • Nov 30
New major risk - Revenue and earnings growth Earnings have declined by 9.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.8% net profit margin). Market cap is less than US$100m (₩42.9b market cap, or US$33.1m). 공시 • Oct 06
BIFIDO Co., Ltd announced that it has received KRW 15 billion in funding On October 4, 2023, BIFIDO Co., Ltd closed the transaction. New Risk • Aug 31
New major risk - Revenue and earnings growth Earnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.5% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩54.8b market cap, or US$41.4m). Reported Earnings • Mar 19
Full year 2022 earnings released: EPS: ₩189 (vs ₩551 in FY 2021) Full year 2022 results: EPS: ₩189 (down from ₩551 in FY 2021). Revenue: ₩14.6b (up 20% from FY 2021). Net income: ₩1.55b (down 66% from FY 2021). Profit margin: 11% (down from 37% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year and the company’s share price has also increased by 4% per year. Valuation Update With 7 Day Price Move • Dec 02
Investor sentiment improved over the past week After last week's 38% share price gain to ₩10,150, the stock trades at a trailing P/E ratio of 73.5x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years. Valuation Update With 7 Day Price Move • May 18
Investor sentiment improved over the past week After last week's 19% share price gain to ₩10,100, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 16x in the Personal Products industry in South Korea. Total loss to shareholders of 36% over the past three years. Reported Earnings • Mar 18
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₩551 (up from ₩68.00 loss in FY 2020). Revenue: ₩12.1b (down 2.1% from FY 2020). Net income: ₩4.49b (up ₩5.05b from FY 2020). Profit margin: 37% (up from net loss in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩10,600, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Negligible returns to shareholders over past year. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₩13,900, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 30x in the Personal Products industry in South Korea. Total returns to shareholders of 68% over the past year. Valuation Update With 7 Day Price Move • Jul 27
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₩14,800, the stock trades at a trailing P/E ratio of 25.1x. Average trailing P/E is 36x in the Personal Products industry in South Korea. Total returns to shareholders of 62% over the past year. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improved over the past week After last week's 17% share price gain to ₩16,750, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 34x in the Personal Products industry in South Korea. Total returns to shareholders of 71% over the past year. Valuation Update With 7 Day Price Move • Jun 21
Investor sentiment improved over the past week After last week's 19% share price gain to ₩13,300, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 31x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past year. Is New 90 Day High Low • Mar 15
New 90-day high: ₩27,750 The company is up 40% from a price of ₩19,800 on 15 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Personal Products industry, which is up 5.0% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: ₩21,350 The company is up 17% from its price of ₩18,250 on 17 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 8.0% over the same period. Is New 90 Day High Low • Oct 05
New 90-day high: ₩20,100 The company is up 3.0% from its price of ₩19,600 on 07 July 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Personal Products industry, which is also up 3.0% over the same period. 
